10-Q 1 ulta-20241102x10q.htm 10-Q
00014035682024Q3--02-01falsehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMemberhttp://fasb.org/us-gaap/2024#NonqualifiedPlanMemberhttp://fasb.org/us-gaap/2024#NonqualifiedPlanMemberhttp://fasb.org/us-gaap/2024#NonqualifiedPlanMember0001403568us-gaap:TreasuryStockCommonMember2024-08-042024-11-020001403568us-gaap:TreasuryStockCommonMember2024-05-052024-08-030001403568us-gaap:TreasuryStockCommonMember2024-02-042024-05-040001403568us-gaap:TreasuryStockCommonMember2023-07-302023-10-280001403568us-gaap:TreasuryStockCommonMember2023-04-302023-07-290001403568us-gaap:TreasuryStockCommonMember2023-01-292023-04-290001403568us-gaap:CommonStockMember2024-08-042024-11-020001403568us-gaap:TreasuryStockCommonMember2024-11-020001403568us-gaap:RetainedEarningsMember2024-11-020001403568us-gaap:AdditionalPaidInCapitalMember2024-11-020001403568us-gaap:TreasuryStockCommonMember2024-08-030001403568us-gaap:RetainedEarningsMember2024-08-030001403568us-gaap:AdditionalPaidInCapitalMember2024-08-030001403568us-gaap:TreasuryStockCommonMember2024-05-040001403568us-gaap:RetainedEarningsMember2024-05-040001403568us-gaap:AdditionalPaidInCapitalMember2024-05-0400014035682024-05-040001403568us-gaap:TreasuryStockCommonMember2024-02-030001403568us-gaap:RetainedEarningsMember2024-02-030001403568us-gaap:AdditionalPaidInCapitalMember2024-02-030001403568us-gaap:TreasuryStockCommonMember2023-10-280001403568us-gaap:RetainedEarningsMember2023-10-280001403568us-gaap:AdditionalPaidInCapitalMember2023-10-280001403568us-gaap:TreasuryStockCommonMember2023-07-290001403568us-gaap:RetainedEarningsMember2023-07-290001403568us-gaap:AdditionalPaidInCapitalMember2023-07-290001403568us-gaap:TreasuryStockCommonMember2023-04-290001403568us-gaap:RetainedEarningsMember2023-04-290001403568us-gaap:AdditionalPaidInCapitalMember2023-04-2900014035682023-04-290001403568us-gaap:TreasuryStockCommonMember2023-01-280001403568us-gaap:RetainedEarningsMember2023-01-280001403568us-gaap:AdditionalPaidInCapitalMember2023-01-280001403568stpr:WY2024-11-020001403568stpr:WV2024-11-020001403568stpr:WI2024-11-020001403568stpr:WA2024-11-020001403568stpr:VT2024-11-020001403568stpr:VA2024-11-020001403568stpr:UT2024-11-020001403568stpr:TX2024-11-020001403568stpr:TN2024-11-020001403568stpr:SD2024-11-020001403568stpr:SC2024-11-020001403568stpr:RI2024-11-020001403568stpr:PA2024-11-020001403568stpr:OR2024-11-020001403568stpr:OK2024-11-020001403568stpr:OH2024-11-020001403568stpr:NY2024-11-020001403568stpr:NV2024-11-020001403568stpr:NM2024-11-020001403568stpr:NJ2024-11-020001403568stpr:NH2024-11-020001403568stpr:NE2024-11-020001403568stpr:ND2024-11-020001403568stpr:NC2024-11-020001403568stpr:MT2024-11-020001403568stpr:MS2024-11-020001403568stpr:MO2024-11-020001403568stpr:MN2024-11-020001403568stpr:MI2024-11-020001403568stpr:ME2024-11-020001403568stpr:MD2024-11-020001403568stpr:MA2024-11-020001403568stpr:LA2024-11-020001403568stpr:KY2024-11-020001403568stpr:KS2024-11-020001403568stpr:IN2024-11-020001403568stpr:IL2024-11-020001403568stpr:ID2024-11-020001403568stpr:IA2024-11-020001403568stpr:HI2024-11-020001403568stpr:GA2024-11-020001403568stpr:FL2024-11-020001403568stpr:DE2024-11-020001403568stpr:CT2024-11-020001403568stpr:CO2024-11-020001403568stpr:CA2024-11-020001403568stpr:AZ2024-11-020001403568stpr:AR2024-11-020001403568stpr:AL2024-11-020001403568stpr:AK2024-11-020001403568us-gaap:RetainedEarningsMember2024-08-042024-11-020001403568us-gaap:RetainedEarningsMember2024-05-052024-08-030001403568us-gaap:RetainedEarningsMember2024-02-042024-05-040001403568us-gaap:RetainedEarningsMember2023-07-302023-10-280001403568us-gaap:RetainedEarningsMember2023-04-302023-07-290001403568us-gaap:RetainedEarningsMember2023-01-292023-04-290001403568us-gaap:LetterOfCreditMemberulta:AmendmentNo.3ToSecondAmendedAndRestatedLoanAgreementMember2024-03-130001403568srt:MaximumMemberulta:AmendmentNo.3ToSecondAmendedAndRestatedLoanAgreementMember2024-03-130001403568us-gaap:RevolvingCreditFacilityMember2024-02-030001403568us-gaap:FairValueInputsLevel2Member2024-11-020001403568us-gaap:FairValueInputsLevel2Member2024-02-030001403568us-gaap:FairValueInputsLevel2Member2023-10-280001403568us-gaap:RestrictedStockUnitsRSUMember2024-11-020001403568us-gaap:PerformanceSharesMember2024-11-020001403568us-gaap:EmployeeStockOptionMember2024-11-020001403568us-gaap:FairValueInputsLevel2Member2024-02-042024-11-020001403568us-gaap:FairValueInputsLevel2Member2023-01-292024-02-030001403568us-gaap:FairValueInputsLevel2Member2023-01-292023-10-280001403568us-gaap:RevolvingCreditFacilityMember2024-11-020001403568us-gaap:RevolvingCreditFacilityMember2023-10-280001403568srt:MinimumMemberulta:AmendmentNo.3ToSecondAmendedAndRestatedLoanAgreementMemberus-gaap:BaseRateMember2024-03-132024-03-130001403568srt:MaximumMemberulta:AmendmentNo.3ToSecondAmendedAndRestatedLoanAgreementMemberus-gaap:BaseRateMember2024-03-132024-03-130001403568srt:MaximumMemberulta:AmendmentNo.3ToSecondAmendedAndRestatedLoanAgreementMember2024-03-132024-03-1300014035682024-08-0300014035682023-07-290001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-08-042024-11-020001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-08-042024-11-020001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-08-042024-11-020001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-08-042024-11-020001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-08-042024-11-020001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-08-042024-11-020001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-08-042024-11-020001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-02-042024-11-020001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-02-042024-11-020001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-02-042024-11-020001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-02-042024-11-020001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-02-042024-11-020001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-02-042024-11-020001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2024-02-042024-11-020001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-07-302023-10-280001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-07-302023-10-280001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-07-302023-10-280001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-07-302023-10-280001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-07-302023-10-280001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-07-302023-10-280001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-07-302023-10-280001403568ulta:SkincareMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-01-292023-10-280001403568ulta:ServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-01-292023-10-280001403568ulta:OtherProductsAndServicesMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-01-292023-10-280001403568ulta:HaircareProductsAndStylingToolsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-01-292023-10-280001403568ulta:FragranceAndBathMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-01-292023-10-280001403568ulta:CosmeticsMemberus-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-01-292023-10-280001403568us-gaap:SalesRevenueNetMemberus-gaap:ProductConcentrationRiskMember2023-01-292023-10-280001403568us-gaap:CommonStockMember2024-11-020001403568us-gaap:CommonStockMember2024-08-030001403568us-gaap:CommonStockMember2024-05-040001403568us-gaap:CommonStockMember2024-02-030001403568us-gaap:CommonStockMember2023-10-280001403568us-gaap:CommonStockMember2023-07-290001403568us-gaap:CommonStockMember2023-04-290001403568us-gaap:CommonStockMember2023-01-2800014035682023-01-280001403568us-gaap:RestrictedStockUnitsRSUMember2024-08-042024-11-020001403568us-gaap:PerformanceSharesMember2024-08-042024-11-020001403568us-gaap:EmployeeStockOptionMember2024-08-042024-11-020001403568us-gaap:RestrictedStockUnitsRSUMember2024-02-042024-11-020001403568us-gaap:PerformanceSharesMember2024-02-042024-11-020001403568us-gaap:EmployeeStockOptionMember2024-02-042024-11-020001403568us-gaap:RestrictedStockUnitsRSUMember2023-07-302023-10-280001403568us-gaap:PerformanceSharesMember2023-07-302023-10-280001403568us-gaap:EmployeeStockOptionMember2023-07-302023-10-280001403568us-gaap:RestrictedStockUnitsRSUMember2023-01-292023-10-280001403568us-gaap:PerformanceSharesMember2023-01-292023-10-280001403568us-gaap:EmployeeStockOptionMember2023-01-292023-10-2800014035682024-11-0200014035682024-02-0300014035682023-10-280001403568us-gaap:CommonStockMember2024-05-052024-08-030001403568us-gaap:CommonStockMember2023-04-302023-07-290001403568us-gaap:AdditionalPaidInCapitalMember2024-08-042024-11-020001403568us-gaap:AdditionalPaidInCapitalMember2024-05-052024-08-0300014035682024-05-052024-08-030001403568us-gaap:CommonStockMember2024-02-042024-05-040001403568us-gaap:AdditionalPaidInCapitalMember2024-02-042024-05-0400014035682024-02-042024-05-040001403568us-gaap:CommonStockMember2023-07-302023-10-280001403568us-gaap:AdditionalPaidInCapitalMember2023-07-302023-10-280001403568us-gaap:AdditionalPaidInCapitalMember2023-04-302023-07-2900014035682023-04-302023-07-290001403568us-gaap:CommonStockMember2023-01-292023-04-290001403568us-gaap:AdditionalPaidInCapitalMember2023-01-292023-04-2900014035682023-01-292023-04-290001403568ulta:AmendmentNo.3ToSecondAmendedAndRestatedLoanAgreementMember2024-03-132024-03-1300014035682022-08-162022-08-1600014035682023-07-302023-10-280001403568srt:MinimumMemberulta:AmendmentNo.3ToSecondAmendedAndRestatedLoanAgreementMember2024-03-132024-03-1300014035682023-01-292023-10-280001403568srt:MaximumMemberulta:ShareRepurchaseProgram2024Member2024-10-310001403568srt:MaximumMemberulta:ShareRepurchaseProgram2024Member2024-03-310001403568srt:MaximumMemberulta:ShareRepurchaseProgram2022Member2022-03-3100014035682024-08-042024-11-0200014035682024-12-0200014035682024-02-042024-11-02xbrli:sharesiso4217:USDxbrli:pureiso4217:USDxbrli:sharesulta:stateulta:store

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended November 2, 2024

or

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _____________ to _____________

Commission File Number: 001-33764

ULTA BEAUTY, INC.

(Exact name of Registrant as specified in its charter)


incorporation or organization)


Identification No.)

Delaware

(State or other jurisdiction of
incorporation or organization)

38-4022268

(I.R.S. Employer
Identification No.)

1000 Remington Blvd., Suite 120

Bolingbrook, Illinois

(Address of principal executive offices)

60440

(Zip code)

Registrant’s telephone number, including area code: (630) 410-4800

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $0.01 per share

ULTA

The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer      Accelerated filer      Non-accelerated filer      Smaller reporting company       Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  No

The number of shares of the registrant’s common stock, par value $0.01 per share, outstanding as of December 2, 2024 was 46,372,538 shares.

ULTA BEAUTY, INC.

TABLE OF CONTENTS

Part I - Financial Information

Item 1.    Financial Statements

Consolidated Balance Sheets

3

Consolidated Statements of Income

4

Consolidated Statements of Cash Flows

5

Consolidated Statements of Stockholders’ Equity

6

Notes to Consolidated Financial Statements

8

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

15

Item 3.    Quantitative and Qualitative Disclosures about Market Risk

24

Item 4.    Controls and Procedures

25

Part II - Other Information

25

Item 1.    Legal Proceedings

25

Item 1A. Risk Factors

25

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

25

Item 3.    Defaults Upon Senior Securities

26

Item 4.    Mine Safety Disclosures

26

Item 5.    Other Information

26

Item 6.    Exhibits

26

SIGNATURES

28

2

Part I - Financial Information

Item 1.Financial Statements

Ulta Beauty, Inc.

Consolidated Balance Sheets

November 2,

February 3,

October 28,

(In thousands, except per share data)

    

2024

    

2024

    

2023

Assets

(Unaudited)

(Unaudited)

Current assets:

Cash and cash equivalents

$

177,782

$

766,594

$

121,811

Receivables, net

213,621

207,939

202,868

Merchandise inventories, net

2,365,186

1,742,136

2,321,306

Prepaid expenses and other current assets

135,514

115,598

117,282

Prepaid income taxes

62,759

4,251

28,773

Total current assets

2,954,862

2,836,518

2,792,040

Property and equipment, net

1,264,419

1,182,335

1,117,874

Operating lease assets

1,619,055

1,574,530

1,578,316

Goodwill

10,870

10,870

10,870

Other intangible assets, net

281

510

591

Deferred compensation plan assets

48,872

43,516

38,371

Other long-term assets

60,127

58,732

56,946

Total assets

$

5,958,486

$

5,707,011

$

5,595,008

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

$

593,219

$

544,001

$

597,373

Accrued liabilities

333,463

382,468

405,443

Deferred revenue

405,040

436,591

350,937

Current operating lease liabilities

284,985

283,821

287,786

Accrued income taxes

11,310

Short-term debt

199,700

195,400

Total current liabilities

1,816,407

1,658,191

1,836,939

Non-current operating lease liabilities

1,656,317

1,627,271

1,616,747

Deferred income taxes

91,729

85,921

56,874

Other long-term liabilities

65,024

56,300

55,906

Total liabilities

3,629,477

3,427,683

3,566,466

Commitments and contingencies (Note 6)

Stockholders' equity:

Common stock, $0.01 par value, 400,000 shares authorized; 47,412, 49,123, and 49,458 shares issued; 46,569, 48,324, and 48,659 shares outstanding; at November 2, 2024 (unaudited), February 3, 2024, and October 28, 2023 (unaudited), respectively

474

491

495

Treasury stock-common, at cost

(106,598)

(83,032)

(82,798)

Additional paid-in capital

1,104,952

1,075,104

1,058,969

Retained earnings

1,330,181

1,286,765

1,051,876

Total stockholders’ equity

2,329,009

2,279,328

2,028,542

Total liabilities and stockholders’ equity

$

5,958,486

$

5,707,011

$

5,595,008

See accompanying notes to consolidated financial statements.

3

Ulta Beauty, Inc.

Consolidated Statements of Income

(Unaudited)

13 Weeks Ended

39 Weeks Ended

November 2,

October 28,

November 2,

October 28,

(In thousands, except per share data)

    

2024

2023

2024

2023

Net sales

$

2,530,100

$

2,488,933

$

7,808,035

$

7,653,005

Cost of sales

1,524,456

1,496,866

4,754,434

4,612,469

Gross profit

1,005,644

992,067

3,053,601

3,040,536

Selling, general and administrative expenses

682,259

661,380

1,992,993

1,874,201

Pre-opening expenses

4,883

3,460

11,957

5,396

Operating income

318,502

327,227

1,048,651

1,160,939

Interest income, net

(1,674)

(2,497)

(13,100)

(14,294)

Income before income taxes

320,176

329,724

1,061,751

1,175,233

Income tax expense

77,997

80,241

253,903

278,597

Net income

$

242,179

$

249,483

$

807,848

$

896,636

Net income per common share:

Basic

$

5.16

$

5.09

$

17.00

$

18.08

Diluted

$

5.14

$

5.07

$

16.93

$

17.99

Weighted average common shares outstanding:

Basic

46,928

49,007

47,519

49,592

Diluted

47,092

49,226

47,710

49,846

See accompanying notes to consolidated financial statements.

4

Ulta Beauty, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

39 Weeks Ended

November 2,

October 28,

(In thousands)

    

2024

    

2023

Operating activities

Net income

$

807,848

$

896,636

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

197,075

181,273

Non-cash lease expense

235,950

232,772

Deferred income taxes

5,808

1,528

Stock-based compensation expense

27,691

33,477

Loss on disposal of property and equipment

7,280

6,310

Change in operating assets and liabilities:

Receivables

(5,682)

(3,446)

Merchandise inventories

(623,050)

(717,855)

Prepaid expenses and other current assets

(19,916)

12,964

Income taxes

(69,818)

9,535

Accounts payable

54,210

41,817

Accrued liabilities

(45,777)

(34,955)

Deferred revenue

(31,551)

(43,740)

Operating lease liabilities

(250,267)

(248,469)

Other assets and liabilities

12,240

(9,836)

Net cash provided by operating activities

302,041

358,011

Investing activities

Capital expenditures

(300,536)

(311,030)

Other investments

(6,108)

(4,870)

Net cash used in investing activities

(306,644)

(315,900)

Financing activities

Borrowings from credit facility

199,700

195,400

Repurchase of common shares

(765,384)

(840,551)

Stock options exercised

9,200

9,302

Purchase of treasury shares

(23,566)

(22,328)

Debt issuance costs

(4,159)

Net cash used in financing activities

(584,209)

(658,177)

Net decrease in cash and cash equivalents

(588,812)

(616,066)

Cash and cash equivalents at beginning of period

766,594

737,877

Cash and cash equivalents at end of period

$

177,782

$

121,811

Supplemental information

Income taxes paid, net of refunds

    

$

316,790

$

266,802

Non-cash capital expenditures

47,431

53,936

See accompanying notes to consolidated financial statements.

5

Ulta Beauty, Inc.

Consolidated Statements of Stockholders’ Equity

(Unaudited)

Treasury -

Common Stock

Common Stock

Additional

Total

Issued

Treasury

Paid-In

Retained

Stockholders'

(In thousands)

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Earnings

    

Equity

Balance – February 3, 2024

49,123

$

491

(799)

$

(83,032)

$

1,075,104

$

1,286,765

$

2,279,328

Net income

313,113

313,113

Stock-based compensation

10,082

10,082

Stock options exercised and other awards

153

2

8,911

8,913

Purchase of treasury shares

(44)

(23,283)

(23,283)

Repurchase of common shares, including excise tax

(588)

(6)

(2,275)

(285,129)

(287,410)

Balance – May 4, 2024

48,688

$

487

(843)

$

(106,315)

$

1,091,822

$

1,314,749

$

2,300,743

Net income

252,556

252,556

Stock-based compensation

9,190

9,190

Stock options exercised and other awards

5

283

283

Purchase of treasury shares

(176)

(176)

Repurchase of common shares, including excise tax

(550)

(6)

(2,098)

(212,332)

(214,436)

Balance – August 3, 2024

48,143

$

481

(843)

$

(106,491)

$

1,099,197

$

1,354,973

$

2,348,160

Net income

242,179

242,179

Stock-based compensation

8,419

8,419

Stock options exercised and other awards

4

4

Purchase of treasury shares

(107)

(107)

Repurchase of common shares, including excise tax

(731)

(7)

(2,668)

(266,971)

(269,646)

Balance – November 2, 2024

47,412

$

474

(843)

$

(106,598)

$

1,104,952

$

1,330,181

$

2,329,009

See accompanying notes to consolidated financial statements.

6

Ulta Beauty, Inc.

Consolidated Statements of Stockholders’ Equity

(Unaudited)

Treasury -

Common Stock

Common Stock

Additional

Total

Issued

Treasury

Paid-In

Retained

Stockholders'

(In thousands)

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Earnings

    

Equity

Balance – January 28, 2023

51,120

$

511

(756)

$

(60,470)

$

1,023,997

$

995,773

$

1,959,811

Net income

347,051

347,051

Stock-based compensation

9,721

9,721

Stock options exercised and other awards

150

1

8,926

8,927

Purchase of treasury shares

(41)

(21,659)

(21,659)

Repurchase of common shares, including excise tax

(541)

(5)

(2,266)

(283,512)

(285,783)

Balance – April 29, 2023

50,729

$

507

(797)

$

(82,129)

$

1,040,378

$

1,059,312

$

2,018,068

Net income

300,102

300,102

Stock-based compensation

11,818

11,818

Stock options exercised and other awards

4

220

220

Purchase of treasury shares

(1)

(100)

(100)

Repurchase of common shares, including excise tax

(594)

(6)

(2,737)

(275,488)

(278,231)

Balance – July 29, 2023

50,139

$

501

(798)

$

(82,229)

$

1,049,679

$

1,083,926

$

2,051,877

Net income

249,483

249,483

Stock-based compensation

11,938

11,938

Stock options exercised and other awards

5

1

154

155

Purchase of treasury shares

(1)

(569)

(569)

Repurchase of common shares, including excise tax

(686)

(7)

(2,802)

(281,533)

(284,342)

Balance – October 28, 2023

49,458

$

495

(799)

$

(82,798)

$

1,058,969

$

1,051,876

$

2,028,542

See accompanying notes to consolidated financial statements.

7

Ulta Beauty, Inc.

Notes to Consolidated Financial Statements

(In thousands, except per share and store count data) (Unaudited)

1.Business and basis of presentation

Ulta Beauty, Inc. was founded in 1990 to operate specialty retail stores selling cosmetics, fragrance, haircare and skincare products, and related accessories and services. Nearly every store features a full-service salon. As used in these notes and throughout this Quarterly Report on Form 10-Q, all references to “we,” “us,” “our,” “Ulta Beauty,” or the “Company” refer to Ulta Beauty, Inc. and its consolidated subsidiaries.

As of November 2, 2024, the Company operated 1,437 stores across 50 states, as shown in the table below.

Number of

Number of

Location

    

stores

    

Location

    

stores

Alabama

27

Montana

6

Alaska

3

Nebraska

5

Arizona

38

Nevada

16

Arkansas

11

New Hampshire

8

California

172

New Jersey

46

Colorado

27

New Mexico

7

Connecticut

21

New York

57

Delaware

4

North Carolina

47

Florida

101

North Dakota

4

Georgia

44

Ohio

48

Hawaii

4

Oklahoma

23

Idaho

10

Oregon

21

Illinois

56

Pennsylvania

46

Indiana

26

Rhode Island

5

Iowa

12

South Carolina

27

Kansas

14

South Dakota

3

Kentucky

16

Tennessee

34

Louisiana

18

Texas

138

Maine

3

Utah

17

Maryland

29

Vermont

1

Massachusetts

27

Virginia

36

Michigan

50

Washington

37

Minnesota

21

West Virginia

7

Mississippi

12

Wisconsin

22

Missouri

26

Wyoming

4

Total

1,437

The accompanying unaudited consolidated financial statements and related notes have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and the U.S. Securities and Exchange Commission’s Article 10, Regulation S-X. These financial statements were prepared on a consolidated basis to include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts, transactions, and unrealized profit were eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary to fairly state the financial position and results of operations and cash flows for the interim periods presented.

8

The Company’s business is subject to seasonal fluctuation, with significant portions of net sales and net income being realized during the fourth quarter of the fiscal year due to the holiday selling season. The results for the 13 and 39 weeks ended November 2, 2024 are not necessarily indicative of the results to be expected for the fiscal year ending February 1, 2025, or for any other future interim period or for any future year.

These unaudited interim consolidated financial statements and the related notes should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended February 3, 2024. All amounts are stated in thousands, with the exception of per share amounts and number of stores.

2.Summary of significant accounting policies

Information regarding significant accounting policies is contained in Note 2, “Summary of significant accounting policies,” to the consolidated financial statements in the Annual Report on Form 10-K for the year ended February 3, 2024. Presented below and in the following notes is supplemental information that should be read in conjunction with “Notes to Consolidated Financial Statements” in the Annual Report.

Fiscal quarter

The Company’s quarterly periods are the 13 weeks ending on the Saturday closest to April 30, July 31, October 31, and January 31. The third quarter in fiscal 2024 and 2023 ended on November 2, 2024 and October 28, 2023, respectively.

Use of estimates

The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the accounting period. Actual results could differ from those estimates. The Company considers its accounting policies relating to inventory valuations, vendor allowances, impairment of long-lived tangible and right-of-use assets, loyalty program and income taxes to be the most significant accounting policies that involve management estimates and judgments. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation.

Recent accounting pronouncements not yet adopted

Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosure. The guidance updates reportable segment disclosure requirements, primarily through requiring enhanced disclosures about significant segment expenses and information used to assess segment performance. The ASU is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07 on related disclosures.

Income Taxes (Topic 740): Improvements to Income Tax Disclosures

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The guidance includes amendments requiring enhanced income tax disclosures, primarily related to standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The guidance is effective for fiscal years beginning after December 15, 2024 and should be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of adopting this ASU on related disclosures.

9

Securities and Exchange Commission (SEC) Climate-Related Disclosures

In March 2024, the SEC adopted rules intended to enhance and standardize climate-related disclosures in registration statements and annual reports. The new rules will require disclosure of material climate-related risks, including disclosure of Board of Directors' oversight and risk management activities, the material impacts of these risks to us and the quantification of material impacts to us as a result of severe weather events and other natural conditions. The rules also require disclosure of material greenhouse gas emissions and any material climate-related targets and goals. The new rules will be effective for annual reporting periods beginning in fiscal year 2025, except for the greenhouse gas emissions disclosures which will be effective for annual reporting periods beginning in fiscal year 2026. However the new rules have been stayed by the federal courts and, as a result, the SEC has indefinitely delayed their effectiveness. The Company is currently evaluating the impact of these new rules.

Income Statement – Reporting Comprehensive Income (Topic 220-40): Expense Disaggregation Disclosures

In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income (Topic 220-40): Expense Disaggregation Disclosures. This update requires, among other things, more detailed disclosure about types of expenses in commonly presented expense captions such as cost of sales and SG&A and is intended to improve the disclosures about an entity’s expenses including purchases of inventory, employee compensation, depreciation, and amortization. The ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact of adopting ASU 2024-03 on the consolidated financial statements and disclosures.

3.Revenue

Net sales include retail stores and e-commerce merchandise sales as well as salon services and other revenue. Other revenue includes the private label and co-branded credit card programs, royalties derived from the partnership with Target Corporation, and deferred revenue related to the loyalty program and gift card breakage.

Disaggregated revenue

The following table sets forth the approximate percentage of net sales by primary category:

13 Weeks Ended  

39 Weeks Ended

November 2,

October 28,

November 2,

October 28,

(Percentage of net sales)

2024

2023

2024

2023

Cosmetics

41%

42%

41%

42%

Skincare

23%

22%

24%

22%

Haircare

20%

21%

19%

21%

Fragrance

10%

9%

10%

9%

Services

4%

4%

4%

4%

Other

2%

2%

2%

2%

100%

100%

100%

100%

Certain sales departments were reclassified between categories in the prior year to conform to current year presentation, including moving the bath category from Fragrance to Skincare.

Deferred revenue

Deferred revenue primarily represents contract liabilities for the obligation to transfer additional goods or services to a guest for which the Company has received consideration, such as unredeemed Ulta Beauty Rewards loyalty points and unredeemed Ulta Beauty gift cards. In addition, breakage on gift cards is recognized proportionately as redemption occurs.

10

The following table provides a summary of the changes included in deferred revenue during the 13 and 39 weeks ended November 2, 2024 and October 28, 2023:

13 Weeks Ended

39 Weeks Ended

November 2,

October 28,

November 2,

October 28,

(In thousands)

2024

2023

2024

    

2023

Beginning balance

$

387,817

$

346,067

$

428,788

$

388,583

Additions to contract liabilities (1)